Careers  |  Sign In  |  Register

Latest in Internal Medicine

A recent study published in Lancet Neurology reveals important associations between MSH3 gene mutations and Huntington’s disease progression and disease burden.
Additional information regarding cellular reprogramming utilizing the innovative tissue nano-transfection technology (TNT).
Current therapeutic options for non-small cell lung cancer (NSCLC) are ever-evolving with the possibility of solely immunotherapy-based treatment regimens on the near horizon for certain patients.